succinylacetone has been researched along with Carcinoma 256, Walker in 2 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tschudy, DP | 2 |
| Ebert, PS | 1 |
| Hess, RA | 2 |
| Frykholm, BC | 2 |
| Atsmon, A | 1 |
| Blaese, RM | 1 |
2 other studies available for succinylacetone and Carcinoma 256, Walker
| Article | Year |
|---|---|
Growth inhibitory activity of succinylacetone: studies with Walker 256 carcinosarcoma, Novikoff hepatoma and L1210 leukemia.
Topics: Animals; Carcinoma 256, Walker; Cell Division; Cells, Cultured; Heme; Hemin; Heptanoates; Heptanoic | 1983 |
Immunosuppressive activity of succinylacetone.
Topics: Animals; Antibody Formation; Carcinoma 256, Walker; Cell Division; Female; Graft Rejection; Hematolo | 1982 |